Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer

被引:3
|
作者
Pantelis, Dimitrios [1 ]
Lingohr, Philipp [1 ]
Hueneburg, Robert [2 ]
Spier, Isabel [3 ]
Vilz, Tim [1 ]
Lau, Jan F. [4 ]
Nattermann, Jacob [2 ]
Aretz, Stefan [2 ]
Strassburg, Christian P. [2 ]
Kalff, Joerg C. [1 ]
机构
[1] Univ Klinikum Bonn, Klin & Poliklin Allgemein Viszeral Thorax & Gefas, Bonn, Germany
[2] Univ Klinikum Bonn, Medizin Klin & Poliklin 1, Allgemeine Innere Med, Bonn, Germany
[3] Univ Klinikum Bonn, Inst Humangenet, Bonn, Germany
[4] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany
来源
ZENTRALBLATT FUR CHIRURGIE | 2020年 / 145卷 / 01期
关键词
hereditary diffuse gastric cancer; CDH1 germline mutation; prophylactic total gastrectomy; laparoscopic surgery; E-CADHERIN GENE; CLASSIFICATION; COMPLICATIONS; GUIDELINES; MANAGEMENT; MUTATIONS; COHORT; FOCI;
D O I
10.1055/a-0646-4382
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Prophylactic total gastrectomy is the treatment of choice in patients with germline mutation in the CDH1 gene and therefore high risk for hereditary diffuse gastric cancer (HDGC). Minimally invasive techniques have been established in recent years for treatment of gastric cancer. Methods We report findings with 12 patients with proven CDH1 mutation who underwent multidisciplinary treatment between 2013 and 3/2018 in our centre for hereditary tu-mour diseases, followed by prophylactic total gastrectomy in our department. Data were collected in a prospective hereditary tumour database. Results Open prophylactic total gastrectomy was performed in 5 patients (between 2013 and 2015) andminimally invasive prospective gastrectomy in 7 patients (between 2015 and 2018). The median age of all patients (7 women and 5 men) was 42 (range: 19-60) years. The mean operation time was 291 +/- 72 minutes (open: 269 +/- 70; minimally invasive: 307 +/- 75). Perioperative 60-day mortality and anastomotic leakage rate were 0%. In 3 patients, postoperative complications occurred (according to the Clavien-Dindo classification: one each of grades II, IIIa and IVb, respectively), and therefore 25% morbidity. The average postoperative hospital stay was 14.5 +/- 6.2 days (open: 16.2 +/- 7.9; minimally invasive: 13.3 +/- 5.0). In 10 of 12 patients (83%), foci of intramucosal signet ring cell carcinomas were found in the gastric specimen, in 9 patients with multifocal dissemination. There were no cases with advanced carcinomas (>= pT1b) or lymph node metastases. Conclusion Patients with suspected high risk for hereditary diffuse gastric cancer should be cared for in a multidisciplinary centre for hereditary tumour diseases. Laparoscopic total gastrectomy is a safe and feasible risk-reducing procedure for patients with CDH1 germline mutation. Therefore, in the absence of contraindications and with available surgical expertise, the minimally invasive operation should be the standard procedure for these patients.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [41] A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
    Yijun Chen
    Kerry Kingham
    James M. Ford
    James Rosing
    Jacques Van Dam
    R. Brooke Jeffrey
    Teri A. Longacre
    Nicki Chun
    Allison Kurian
    Jeffrey A. Norton
    Annals of Surgical Oncology, 2011, 18 : 2594 - 2598
  • [42] Laparoscopic Prophylactic Total Gastrectomy With Linear Stapler Side-to-Side Esophagojejunal Anastomosis for Hereditary Diffuse Gastric Cancer Syndrome in 2 Siblings
    Li, Jihui
    McBean, Etwar
    Li, Xinxiang
    Berho, Mariana
    Szomstein, Samuel
    Rosenthal, Raul J.
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2013, 23 (03): : E124 - E126
  • [43] Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations—a clinical observational study
    Linda Bardram
    Thomas V. O. Hansen
    Anne-Marie Gerdes
    Susanne Timshel
    Lennart Friis-Hansen
    Birgitte Federspiel
    Familial Cancer, 2014, 13 : 231 - 242
  • [44] Hereditary diffuse gastric cancer: Prophylactic surgical oncology implications
    Lynch, Heiiry T.
    Silva, Edibaldo
    Wirtzfeld, Debrah
    Hebbard, Pamela
    Lynch, Jane
    Huntsman, David G.
    SURGICAL CLINICS OF NORTH AMERICA, 2008, 88 (04) : 759 - +
  • [45] Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study
    Bardram, Linda
    Hansen, Thomas V. O.
    Gerdes, Anne-Marie
    Timshel, Susanne
    Friis-Hansen, Lennart
    Federspiel, Birgitte
    FAMILIAL CANCER, 2014, 13 (02) : 231 - 242
  • [46] A Systematic Review on Clinical and Health-Related Quality of Life Outcomes following Total Gastrectomy in Patients with Hereditary Diffuse Gastric Cancer
    Lim, Hui Jun
    di Pietro, Massimiliano
    ONeill, J. Robert
    CANCERS, 2024, 16 (03)
  • [47] Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
    Munitiz, Vicente
    Jimeno, Pilar
    Ruiz-de-Angulo, David
    Ortiz, Angeles
    Martinez-De-Haro, Luisa F.
    Marin, Miguel
    Cascales, Pedro
    Ruiz-Garcia, Gema
    Ortiz-Ruiz, Eduardo
    Parrilla, Pascual
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (03) : 189 - 192
  • [48] Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series
    Olsi Gjyshi
    Pankaj Vashi
    Laura Seewald
    Mitra Kohan
    Elham Abboud
    Eric Fowler
    Revathi Suppiah
    Hatem Halabi
    World Journal of Surgical Oncology, 16
  • [49] Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series
    Gjyshi, Olsi
    Vashi, Pankaj
    Seewald, Laura
    Kohan, Mitra
    Abboud, Elham
    Fowler, Eric
    Suppiah, Revathi
    Halabi, Hatem
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [50] An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC)
    Nina Hallowell
    Shirlene Badger
    Sue Richardson
    Carlos Caldas
    Richard H. Hardwick
    Rebecca C. Fitzgerald
    Julia Lawton
    Familial Cancer, 2016, 15 : 665 - 676